Cidara Therapeutics

Yahoo Finance • 12 days ago

Merck Poised for Mid-Single-Digit Revenue Growth in Fiscal 2026, BofA Says

Merck (MRK) is expected to deliver mid-single-digit revenue growth in fiscal 2026 driven primarily b PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 17 days ago

Halper Sadeh LLC Encourages CADE, MRSN, CDTX Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 17 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mersana Therapeutics, Inc. (Nasdaq - MRSN), Cidara Therapeutics, Inc. (Nasdaq - CDTX), Cadence Bank (NYSE – CADE)

BALA CYNWYD, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 19 days ago

Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 22 days ago

Is This Pharmaceutical Giant a Buy After a Major Acquisition?

Key Points Merck's newest acquisition could help it launch a promising flu candidate. Several other ongoing developments are helping paint a bright post-Keytruda picture. Merck is also an excellent dividend payer. 10 stocks we like better... Full story

Yahoo Finance • 23 days ago

The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch.

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking to make deals. Continue Reading... Full story

Yahoo Finance • 29 days ago

Halper Sadeh LLC Encourages AXTA, SEMR, CDTX Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 29 days ago

HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- We wish you a Happy Thanksgiving and Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), who has recovered millions of dollars for shareholders... Full story

Yahoo Finance • last month

Analysts Shift to Hold as Cidara’s (CDTX) Recent Acquisition Deal Caps Upside

Cidara Therapeutics Inc. (NASDAQ:CDTX) is the top stock in our list of the hottest SMID-cap stocks so far in 2025 with a 717% share price surge year-to-date. Following the acquisition announcement by Merck & Co. Inc. (NYSE:MRK), Guggenheim... Full story

Yahoo Finance • last month

Which of Goldman's hedge fund favorites is the best buy, as per SA Quant ratings?

[Emerging Financial Data - Stock Market, Prosperity, Bull Market - Blue Version] DKosig Goldman Sachs analysts updated their hedge fund VIP list—the 50 stocks that most frequently appear in the top 10 holdings of fundamental funds—on Thur... Full story

Yahoo Finance • last month

Halper Sadeh LLC Encourages THS, CDTX, SPNS Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Nov. 22, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • last month

Biotech Stock Gets Booted in Latest Fund Update

Key Points Sold 1,447,267 shares, a net position change of $110.43 million Post-trade stake: 0 shares, $0 value The position was previously 13.8% of the fund's AUM as of the prior quarter, marking a significant portfolio shift These 10 st... Full story

Yahoo Finance • last month

Cidara (CDTX) Climbs 105% on $9.2-Billion Merger with Merck

We recently published 10 Market Movers That Made Millionaires in a Week. Cidara Therapeutics Inc. (NASDAQ:CDTX) is one of the best-performing stocks of the past trading week. Cidara Therapeutics soared by more than 100 percent week-on-wee... Full story

Yahoo Finance • last month

Top global stories this week: Merck, SoftBank, Novo Nordisk among notable names

US stock indexes ended the week lower as investors reassessed the likelihood of a December rate cut, and the tech sector remained strained over stretched valuations in AI-related stocks. For the week, the S&P 500 (SP500 [https://seekingal... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Health insurers, Eli Lilly, Merck in focus

Wall Street saw a mixed week, with the benchmark S&P 500 Index adding a marginal 0.08%, the NASDAQ Composite Index losing 0.45%, and the Dow Jones Industrial Average Index rising 0.34%. However, the S&P 500 Health Care Index Sector (XLV [... Full story

Yahoo Finance • last month

Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more

Here's a list of key deals reported across sectors this week: Merck (MRK [https://seekingalpha.com/symbol/MRK]) to acquire [https://seekingalpha.com/pr/20307875-merck-to-acquire-cidara-therapeutics-inc-diversifying-its-portfolio-to-includ... Full story

Yahoo Finance • last month

RFK Jr. considered limiting FDA Commissioner Makary's role - report

[President Trump Announces Negotiated Lower Prices For GLP-1 Weight Loss Drugs] Andrew Harnik/Getty Images News HHS Secretary RFK Jr. allegedly considered limiting the role of FDA Commissioner Marty Makary and assigning another official t... Full story

Yahoo Finance • last month

Cidara Therapeutics (CDTX) Skyrockets 105% on Merck $9.2-Billion Acquisition Bid

We recently published Lackluster Market? Not for These 10 Soaring Stocks. Cidara Therapeutics, Inc. (NASDAQ:CDTX) is one of the best-performing stocks on Friday. Cidara Therapeutics soared to nearly a decade high on Friday, as investors g... Full story

Yahoo Finance • last month

Stocks Settle Mixed as Fed Comments Suggest a Rate Cut Pause

The S&P 500 Index ($SPX) (SPY) on Friday closed down -0.05%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.65%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.06%.  December E-mini S&P futures (ESZ25) fell -0.02%, and D... Full story

Yahoo Finance • last month

Wall Street ends mixed; traders look to Nvidia report

STORY: U.S. stocks ended mixed on Friday, with the Dow dropping about two-thirds of a percent, the S&P 500 closing essentially flat and the Nasdaq ticking up marginally.An early selloff dragged all three major indexes down more than 1% bef... Full story